Reconvened Sixty-sixth session

Vienna, Austria, 7-8 December 2023

Meeting times (Vienna, CET):

7 December 2023: 10 a.m. - 1 p.m. and 3 p.m. - 6 p.m.

8 December 2023: 10 a.m. - 1 p.m.

In-session Draft Reports

Draft proposals and in-session draft reports are available here.

Presentations

PRE-SESSION DOCUMENTATION

Document Symbol	Title or description
E/CN.7/2023/1/Add.1	Provisional agenda, annotations and proposed organization of work (Addendum)
E/CN.7/2023/3/Add.1-E/CN.15/2023/3/Add.1	Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime (Addendum)
E/CN.7/2023/12-E/CN.15/2023/16	Report of the Executive Director on gender balance and geographical representation
E/CN.7/2023/13-E/CN.15/2023/17	Report of the Executive Director on the consolidated budget for the biennium 2024-25 for the United Nations Office on Drugs and Crime
E/CN.7/2023/14- E/CN.15/2023/18	Report of the Advisory Committee on Administrative and Budgetary Questions on the consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime
	Conference Room Papers (CRP)
E/CN.7/2023/CRP.15 - E/CN.15/2023/CRP.11	Draft proposed programme plan for 2025 and programme performance for 2023 for the United Nations Office on Drugs and Crime
E/CN.7/2023/CRP.16	Summary of assessments, findings and recommendations of the 46th World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD), 16–19 October 2023
E/CN.7/2023/CRP.17	Draft organization of the high-level segment to take stock of the implementation of all international drug policy commitments and outline the way forward to 2029, in line with the Ministerial Declaration of 2019 (14-15 March 2024)
E/CN.7/2023/CRP.18	Report of the Executive Director on progress made in the implementation of all international drug policy commitments to address and counter the world drug problem - ADVANCE VERSION
E/CN.7/2023/CRP.19	Notification from the President of the International Narcotics Control Board to the Chair of the Commission on Narcotic Drugs on its sixty-seventh session concerning the scheduling of P-2-P methyl glycidic acid (“BMK glycidic acid”) and its methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, and tert-butyl esters under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
E/CN.7/2023/CRP.20	Notification from the President of the International Narcotics Control Board to the Chair of the Commission on Narcotic Drugs on its sixty-seventh session concerning the scheduling of the ethyl ester of 3,4-MDP-2-P methyl glycidic acid (“PMK ethyl glycidate”) and of six additional esters of 3,4-MDP-2-P methyl glycidic acid under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
E/CN.7/2023/CRP.21	Notification from the President of the International Narcotics Control Board to the Chair of the Commission on Narcotic Drugs on its sixty-seventh session concerning the scheduling of 4-piperidone and 1-boc-4-piperidone under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
	Additional documents
A/HRC/54/53	Report of the Office of the United Nations High Commissioner for Human Rights: Human rights challenges in addressing and countering all aspects of the world drug problem
	Report
E/CN.7/2023/11/Add.1- E/2023/28/Add.1	Report on the reconvened sixty-sixth session of the Commission on Narcotic Drugs
E/CN.7/2023/CRP.14	List of documents before the Commission at its reconvened 66th session